Mr. Speaker, every step of the way, we have leaned in to work with companies and manufacturers that are developing new tools to fight COVID-19, including testing solutions. The world is eagerly awaiting rapid tests, saliva tests and new technology that will help us diagnose quickly people who have COVID-19.
On our end, our job is to ensure that provinces and territories have what they need to deliver on health care in their jurisdictions, and that is exactly what we have been doing all along. Whether it is the $19 billion in safe restart money, or the procurement and deployment of rapid tests, we will be there for provinces and territories.